TYR rs1042602: Understanding the S192Y Pigmentation Variant

What each genotype means

What is rs1042602?

The variant rs1042602 is a missense mutation in the TYR gene, where a cytosine (C) is replaced by an adenine (A). This specific change results in the substitution of the amino acid serine with tyrosine at position 192 of the tyrosinase protein, commonly denoted as S192Y. Located on chromosome 11, this SNP is one of several common variations within the TYR gene that have been identified through large-scale genomic studies. Because it alters the protein sequence, researchers have long investigated whether this change impacts the function of the enzyme. While it is a well-documented polymorphism, its functional consequences are nuanced, and it is often studied alongside other nearby variants in the same gene, such as R402Q, which can complicate the interpretation of its individual effects on human traits.

The Role of the TYR Gene

The TYR gene provides instructions for making an enzyme called tyrosinase. This enzyme is primarily active in melanocytes, which are specialized cells that produce melanin, the pigment responsible for the color of our skin, hair, and eyes. Tyrosinase acts as the rate-limiting enzyme in the melanogenesis pathway, meaning it controls the speed at which melanin is synthesized. It catalyzes the initial steps of converting the amino acid tyrosine into dopaquinone, a precursor that eventually leads to the production of either eumelanin (brown/black pigment) or pheomelanin (red/yellow pigment). Because tyrosinase is essential for the production of melanin, variations in the TYR gene can influence the amount and type of pigment produced, which is why this gene is a primary focus in studies regarding human pigmentation diversity and skin health.

Research and Associations

Research has linked rs1042602 to various pigmentation traits, including freckling and skin color variation, particularly in European and South Asian populations. Beyond normal trait variation, the variant has been investigated as a potential risk factor for melanoma. Some studies have suggested that the A allele may be associated with an increased susceptibility to melanoma, potentially due to its influence on melanin production or the cellular response to UV radiation. However, the evidence is considered limited and sometimes mixed; for instance, some studies have found significant associations in specific cohorts, while others have not observed the same effect. Furthermore, recent pilot research has explored its association with conditions like melasma. Because these associations can be influenced by ancestry and environmental factors, the clinical significance of this variant remains an area of active scientific inquiry rather than a definitive diagnostic marker.

Population Frequency

The rs1042602 variant is not distributed uniformly across all human populations. It is most commonly observed in individuals of European ancestry, where the minor allele frequency (MAF) is approximately 0.18. In contrast, the variant is rare or absent in many other global populations. This uneven distribution is a common feature of many pigmentation-related variants, which have often been subject to different evolutionary pressures depending on the geographic region and historical UV exposure of ancestral populations. Because the frequency is relatively high in certain groups, it is frequently included in genome-wide association studies (GWAS) that aim to map the genetic architecture of human physical traits. Understanding these frequency differences is crucial for researchers to avoid bias and ensure that genetic findings are interpreted within the correct ancestral context.

What This Information Means for You

If you have received information about your rs1042602 genotype, it is important to view it as a piece of data regarding human trait variation rather than a medical diagnosis. While some research suggests an association with melanoma risk, this does not mean that carrying a specific genotype guarantees or precludes the development of any condition. Genetic associations are statistical in nature and often represent only a small fraction of the total risk, which is also heavily influenced by lifestyle, sun exposure, and other genetic factors. You cannot use this information to predict your health outcomes or replace professional medical screenings. If you have concerns about your skin health or personal risk factors for melanoma, the most effective step is to consult with a dermatologist or a healthcare provider. They can provide personalized advice based on your full medical history and clinical examination.

Frequently asked questions

Sources & further reading

Related variants in TYR